- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07401212
GUTLINK4KIDS Intervention (GUTLINK4KIDS)
April 27, 2026 updated by: Piril Hepsomali, University of Reading
The Impact of Chronic Consumption of Prebiotics on Cognitive and Affective Outcomes, Gut Microbiome Diversity and Composition in 3-5 Year Olds: a Double-blind Placebo-controlled, Parallel-groups Randomised Controlled Trial
This study aims to investigate the chronic effects of prebiotic consumption on cognitive, behavioural and gut microbiome outcomes in children aged 3-5 years.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study will employ a double-blind, randomised, placebo-controlled parallel design to investigate the chronic effects of 8-week-long prebiotic consumption on cognitive, behavioural, and gut microbiome, outcomes in 3-5-year-old children with insufficient fibre intake (less than the average 10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds).
One hundred and six participants will be randomised to Intervention or Placebo groups where they will be consuming 5g of prebiotic fibre or 5g of placebo (matched placebo powder) per day for 8-weeks.
Outcome measures will be acquired before and after a 8-week chronic supplementation.
These will include cognitive and behavioural outcomes of the parents and children.
In addition, stool samples will be collected at the baseline and at week 8 to assess microbiome diversity and composition.
Additionally, after 4-weeks of wash-out, at 12 weeks, parents will be asked to completed online questionnaires assessing cognitive and behavioural outcome of their children.
Study Type
Interventional
Enrollment (Estimated)
106
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Piril Hepsomali, PhD
- Phone Number: +44 118 378 5818
- Email: p.hepsomali@reading.ac.uk
Study Locations
-
-
Berkshire
-
Reading, Berkshire, United Kingdom, RG6 6BZ
- Recruiting
- University of Reading, School of Psychology and Clinical Languages
-
Contact:
- Piril Hepsomali, PhD
- Phone Number: +44 118 378 5818
- Email: p.hepsomali@reading.ac.uk
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Parents (18 years and over) of generally healthy children aged 3-5-years-old (36-71 months) with lower dietary fibre intake than the recommended daily amount (10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds).
Exclusion Criteria:
- Children with a significant acute or chronic co-existing illness (including inflammatory bowel disease, functional gastrointestinal disorders, coeliac disease etc, neurodevelopmental, immunological, psychiatric, or metabolic disorders.
- Children who have taken any pre/probiotic supplements or antibiotic treatment within the 4 weeks prior to enrolment.
- Children with food allergies and intolerances
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Prebiotic (powder)
Children will consume two (one in the morning and one in the evening) 2.5g of prebiotic sachets a day (mixed with food and drink).
|
5g of prebiotic fibre
|
|
Placebo Comparator: Matched placebo (powder)
Children will consume two (one in the morning and one in the evening) 2.5g of placebo sachets a day (mixed with food and drink).
|
5g of placebo
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Child Behaviour Checklist Ages 1.5-5
Time Frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
|
Parents will be asked to complete this validated measure that includes 100 items that assesses a child's emotional, behavioral, and social problems.
|
This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Emotion Regulation Skills Questionnaire
Time Frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
|
Parents will be asked to complete this measure that includes 52 items that assesses a child's adaptive and maladaptive emotion regulation skills.
|
This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
|
|
Childhood Autism Spectrum Test
Time Frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
|
Parents will be asked to complete this measure that includes 44 items that assesses a child's developmental differences in social and communication functioning
|
This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
|
|
Bristol Stool Chart
Time Frame: This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
|
Parents will be asked to complete this measure that includes 1 item that assesses a child's stool consistency.
|
This measure will be taken at baseline (pre intervention), week 8 (post intervention) and week 12 (after 4-week wash-out)
|
|
Gut microbiome diversity
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
Children's stool samples will be collected to measure gut microbiome diversity.
Indices of alpha and beta diversity will be analysed (16s sequencing).
|
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
|
Gut microbiome composition
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
Children's stool samples will be collected to measure gut microbiome composition (genus and species) (16s sequencing).
|
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Attentional Control Scale
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
Parents will be asked to complete this measure that includes 20 items that assesses their own attentional control.
|
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
|
Difficulties in Emotional Regulation Scale
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
Parents will be asked to complete this measure that includes 36 items that assesses their own emotion regulation skills.
|
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
|
Patient Health Questionnaire-8
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
Parents will be asked to complete this measure that includes 8 items that assesses their own depressed mood.
|
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
|
Generalised Anxiety Disorder-7
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
Parents will be asked to complete this measure that includes 7 items that assesses their own anxious mood.
|
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
|
Child-Parent Relationship Scale
Time Frame: This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
Parents will be asked to complete this measure that includes 30 items that assesses their relationship with their child/children.
|
This measure will be taken at baseline (pre intervention) and week 8 (post intervention).
|
|
Scottish Collaborative Group Child VC2 Food Frequency Questionnaire
Time Frame: This measure will be taken at baseline (pre intervention).
|
Parents will be asked to complete this measure that assesses their child's habitual food intake.
|
This measure will be taken at baseline (pre intervention).
|
|
Child Eating Behaviour Questionnaire
Time Frame: This measure will be taken at baseline (pre intervention).
|
Parents will be asked to complete this measure that assesses their child's eating behaviour.
|
This measure will be taken at baseline (pre intervention).
|
|
Dietary recall
Time Frame: This measure will be taken during screening and at week 8 (post intervention).
|
This measure will be used to screen participants.
Parents will be asked to complete this measure that assesses their child's food intake.
Children with insufficient fibre intake (less than the average 10.4g/day in 18-47-month-olds and less than 12.6g/day in 48-60-month-olds) will be eligible for the study.
|
This measure will be taken during screening and at week 8 (post intervention).
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 2, 2026
Primary Completion (Estimated)
February 1, 2027
Study Completion (Estimated)
February 1, 2027
Study Registration Dates
First Submitted
February 3, 2026
First Submitted That Met QC Criteria
February 3, 2026
First Posted (Actual)
February 10, 2026
Study Record Updates
Last Update Posted (Actual)
April 28, 2026
Last Update Submitted That Met QC Criteria
April 27, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- UREC25_38
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Sleep
-
University of Wisconsin, MadisonPhilips HealthcareCompletedSleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization
-
Brain Electrophysiology Laboratory CompanyRecruiting
-
University GhentEuropean CommissionCompleted
-
Mahidol UniversityRamathibodi HospitalNot yet recruitingSleep Inertia | Sleep, Slow-wave Sleep, Sleep Enhancement, Sleep Optimization | Night Shift WorkThailand
-
Northumbria UniversityCompletedSleep | Mood | Poor Quality Sleep | Good Sleep HabitUnited Kingdom
-
Universidade Federal de PernambucoEnrolling by invitationSleep | Obstructive Sleep Apnea (OSA)Brazil
-
Atlas UniversityCompletedSleep | Surgery | Sleep QualityTurkey (Türkiye)
-
Mersin UniversityCompletedSleep Quality | Sleep PerceptionTurkey (Türkiye)
-
Brigham and Women's HospitalNot yet recruitingObstructive Sleep Apnea | Sleep-disordered BreathingUnited States
-
Institute of Nutrition, Slovenia (Nutris)Valens Int. d.o.o., Slovenija; Faculty of Pharmacy, University of Ljubljana... and other collaboratorsNot yet recruitingSleep Quality | Sleep Onset LatencySlovenia
Clinical Trials on Prebiotic powder
-
Myota GmbHUniversity of ReadingRecruitingStressUnited Kingdom
-
BLIS Technologies LimitedRecruiting
-
Mayo ClinicCompleted
-
University of the PunjabUniversity of Veterinary and Animal Sciences, Lahore - PakistanNot yet recruitingChild MalnutritionPakistan
-
AIDP, Inc.KGK Science Inc.CompletedHealthy | Functional ConstipationCanada
-
John HaleRecruitingLower Respiratory Tract Infection | Upper Respiratory Tract InfectionNew Zealand
-
Beneo-InstituteUniversity of ReadingCompletedMoodUnited Kingdom
-
Centros de Investigación de Nutrición y SaludNutribioticaCompletedFunctional ConstipationSpain
-
Rush University Medical CenterCures Within ReachCompletedPost Traumatic Stress DisorderUnited States
-
University of RoehamptonActive, not recruitingHealthy SubjectsUnited Kingdom